Effects of ferric carboxymaltose on markers of mineral and bone metabolism: a single-center prospective observational study of women with iron deficiency

BACKGROUND: Two weekly infusions of ferric carboxymaltose (FCM) are commonly prescribed for treatment of iron-deficiency anemia. However, administration of FCM increases intact levels of fibroblast growth factor 23 (FGF23), which causes hypophosphatemia due to renal phosphate wasting, calcitriol def...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Bone
Main Authors: Frazier, Rebecca, Hodakowski, Alexander, Cai, Xuan, Lee, Jungwha, Zakarija, Anaadriana, Stein, Brady, David, Valentin, Wolf, Myles, Isakova, Tamara, Mehta, Rupal
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7680361/
https://ncbi.nlm.nih.gov/pubmed/32730929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bone.2020.115559
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados